Houman Mesghali

Houman Mesghali has a diverse professional background in the pharmaceutical industry, with experience at Teva Pharmaceuticals and MD Anderson Cancer Center. Currently, Mesghali is the Co-Founder and COO at CTMC, a joint venture between Resilience and MD Anderson Cancer Center. Mesghali holds an MBA in Finance & Management from The Johns Hopkins University - Carey Business School and an M.Sc. in Molecular Biology from the University of Maryland.